About the conference
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
The “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business, science, clinics, finance, regulatory affairs and intellectual property.
See an overview of highlights of the 2019 AMR Conference below.
The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong network of more than 60 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. The aim is to establish the AMR Conference as the one-stop-shop in Europe to meet all AMR relevant stakeholders.
The European Biotechnology Magazine with its website european-biotechnology.com is the major media partner of the AMR Conference. It is a quarterly publication with a distribution of 10,000 copies across Europe which is supported by many national biotech associations.
What was different for the AMR Conference 2020?
In view of the continuing uncertain situation and travel restrictions due to the COVID-19 pandemic, we implemented the 4th AMR Conference as a digital format in the week of 24–28 August 2020.
The current global health crisis caused by COVID-19 shows more than ever the importance of infectious diseases expertise and the high need for further fighting against antimicrobial resistance (AMR). A cross-sectoral international dialogue with all stakeholders involved will be crucial to help implement innovative therapies and diagnostics in the clinical practice globally.
Together with our supporters – among others our major partner, the BEAM Alliance – the AMR Conference will continue to provide a (virtual) platform for those debates bringing together stakeholders from industry, SMEs, start-ups, academia, clinics, investors, public institutions and policy. Within our digital AMR Conference Week in August, we caught up discussing the challenges of bringing new antimicrobial treatments and diagnostics into the market.
Five days of insights and networking for the global AMR community: Each conference day covered a focus topic with selected LIVE sessions and high-level panels. Additionally, you were able to explore scientific poster presentations and participate in virtual 1:1 meetings throughout the whole week and to engage within our new digital AMR stakeholder platform.
The #AMRconference 2020 was a great success. Almost 450 international AMR experts have participated in 26 live sessions which provided a 360 degree overview of the current AMR industry and resulted in engaging discussions.
We look forward to welcoming you again in summer – hopefully face-to-face.
Here are some key takeaways from the Closing Session:
#AMRconference 2019 highlights:
- The 2019 conference took place 14–15 March in Berlin, Germany:
- 332 delegates from 23 countries
- 200+ pre-scheduled investor partnering meetings
- A poster session with 50 posters, and an exhibition in the main networking area
- One health approach with a focus on human and animal health
- 75 speakers discussing current issues in various focused tracks
- 12 sessions covering these topics: Financing and funding | Start-up pitch | Clinical development and market access | Therapeutics and diagnostics | Surveillance | R&D trends
- Policy forum & workshop on AMR financing, co-organised with World Health Organization (WHO) and United Nations Conference on Trade and Development (UNCTAD
- Pre-conference workshop on ‘Resistance testing – beyond serial passage experiments’, jointly supported by NOVO Repair Impact Fund, GARDP, CARB-X and Wellcome Trust
- Congratulations to the winner of the Start-up Pitch, Özden Baltekin of Astrego Diagnostics AB, and the winners of the Poster Prize, Franziska Mandl (aBACTER, Technical University of Munich) and Matteo Ceccarelli (University of Cagliari)
- Supported by our Sponsors, partners and exhibitors
About the Organiser
- Swiss Biotech Day
- Global Bioeconomy Summit
- The European Forum on Industrial Biotechnology and Bioeconomy